| 51 |
12962785 | A low incidence of new-onset insulin-dependent diabetes mellitus using tacrolimus in kidney recipients in Europe. | 2003 Aug |
1 |
| 52 |
14557767 | Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. | 2003 Oct 15 |
1 |
| 53 |
14625173 | [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease]. | 2003 Nov |
1 |
| 54 |
11752040 | Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. | 2002 Jan |
1 |
| 55 |
12196452 | A case showing complete insulin independence after severe diabetic ketoacidosis associated with tacrolimus treatment. | 2002 Sep |
1 |
| 56 |
12486498 | Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. | 2002 Dec |
2 |
| 57 |
11181807 | Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. | 2001 Mar |
2 |
| 58 |
11213069 | Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. | 2001 Jan 27 |
1 |
| 59 |
11520309 | Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation. | 2001 Aug |
3 |
| 60 |
11743719 | DAF-16-dependent and independent expression targets of DAF-2 insulin receptor-like pathway in Caenorhabditis elegans include FKBPs. | 2001 Dec 14 |
1 |
| 61 |
10831643 | Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. | 2000 Jun |
2 |
| 62 |
10989953 | Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus. | 2000 |
1 |
| 63 |
9723345 | Clinical use of the euglycemic hyperinsulinemic clamp for diagnosis of tacrolimus-induced insulin resistance after combined pancreas-kidney transplantation. | 1998 Aug |
1 |
| 64 |
9113492 | Post-transplant diabetes mellitus. The role of immunosuppression. | 1997 Apr |
1 |
| 65 |
8611359 | Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients. | 1996 Feb |
1 |
| 66 |
8981925 | Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. | 1996 Dec 15 |
11 |
| 67 |
7542815 | The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. | 1995 Jul 27 |
1 |
| 68 |
7544064 | [A case of tacrolimus-induced glucose intolerance following renal allografting]. | 1995 Jun |
2 |
| 69 |
7506454 | Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. | 1993 Dec |
1 |
| 70 |
7678356 | Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. | 1993 Jan |
2 |
| 71 |
7679839 | Long-term insulin requirement after liver transplantation with FK 506 in American veterans. | 1993 Feb |
1 |
| 72 |
7692637 | Insulin requirements after liver transplantation and FK-506 immunosuppression. | 1993 Oct |
1 |
| 73 |
1716797 | In vivo effect of FK506 on human pancreatic islets. | 1991 Sep |
1 |
| 74 |
1721286 | Inhibition of insulin release by FK 506 and its prevention by rioprostil, a stable prostaglandin E1 analogue. | 1991 Dec |
1 |